Discovery of F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions

scientific article published on 02 November 2018

Discovery of F-JK-PSMA-7, a novel PET-probe for the detection of small PSMA positive lesions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2967/JNUMED.118.218495
P932PMC publication ID6581226
P698PubMed publication ID30389823

P50authorBoris D. ZlatopolskiyQ55241227
Heike EndepolsQ88619102
P2093author name stringBernd Neumaier
Alexander Drzezga
Markus Dietlein
Philipp Krapf
Raphael Richarz
Elizaveta A Urusova
Melanie Hohberg
Mehrab Guliyev
P2860cites workDetection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell CarcinomaQ40278887
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate CancerQ41319390
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate CancerQ41905456
Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18F-DCFPyL: Variability in Normal-Organ UptakeQ45105171
Tetrabutylammonium tetra(tert-butyl alcohol)-coordinated fluoride as a facile fluoride sourceQ46339661
High-resolution 3D Bayesian image reconstruction using the microPET small-animal scannerQ46802169
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer.Q47156816
Discovery of 7-[18F]Fluorotryptophan as a Novel Positron Emission Tomography (PET) Probe for the Visualization of Tryptophan Metabolism in VivoQ48154779
Neither azeotropic drying, nor base nor other additives: a minimalist approach to (18)F-labelingQ85252798
Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin InhibitorsQ27684776
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancerQ28236013
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patientsQ33841484
An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [(18) F]DCFPyL.Q33917903
Practical aspects of the ligand-binding and enzymatic properties of human serum albumin.Q34702948
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate CancerQ35938051
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?Q36421964
Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted NicotinatesQ36818334
Chemical control over immune recognition: a class of antibody-recruiting small molecules that target prostate cancerQ37478039
How to design PET experiments to study neurochemistry: application to alcoholismQ37615648
PSA-Stratified Performance of 18F- and 68Ga-PSMA PET in Patients with Biochemical Recurrence of Prostate Cancer.Q38788408
(18)F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistributionQ38815886
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancerQ39449818
Automated synthesis of [(18)F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models.Q39797249
P433issue6
P407language of work or nameEnglishQ1860
P304page(s)817-823
P577publication date2018-11-02
P1433published inThe Journal of Nuclear MedicineQ7743608
P1476titleDiscovery of 18F-JK-PSMA-7, a PET Probe for the Detection of Small PSMA-Positive Lesions
P478volume60

Reverse relations

cites work (P2860)
Q9242392618F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging
Q9014087468Ga-PSMA I&T PET/CT for primary staging of prostate cancer
Q92190795Biodistribution and radiation dosimetry of [18F]-JK-PSMA-7 as a novel prostate-specific membrane antigen-specific ligand for PET/CT imaging of prostate cancer
Q64911922Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.
Q89529826Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology

Search more.